ACADIA PHARMACEUTICALS INC Annual Net Cash Provided by (Used in) Financing Activities in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Acadia Pharmaceuticals Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2023.
  • Acadia Pharmaceuticals Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $1.04M, a 28.9% decline year-over-year.
  • Acadia Pharmaceuticals Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $25.1M, a 206% increase from 2022.
  • Acadia Pharmaceuticals Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was $8.2M, a 54.9% decline from 2021.
  • Acadia Pharmaceuticals Inc annual Net Cash Provided by (Used in) Financing Activities for 2021 was $18.2M, a 77.6% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $25.1M +$16.9M +206% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $8.2M -$9.96M -54.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $18.2M -$62.8M -77.6% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $81M -$291M -78.2% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $372M +$65.2M +21.3% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $307M +$275M +883% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $31.2M -$503M -94.2% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 $534M Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2012 $98.2M +$84.2M +604% Jan 1, 2012 Dec 31, 2012 10-K 2013-03-12
2011 $13.9M +$13.5M +2867% Jan 1, 2011 Dec 31, 2011 10-K 2013-03-12
2010 $470K Jan 1, 2010 Dec 31, 2010 10-K 2013-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.